Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection (Q33400777)

26 July 2017

title

Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection (English)

1 reference

26 July 2017

6

Chikako Shimizu

1 reference

26 July 2017

9

Yasuhiro Fujiwara

1 reference

26 July 2017

5

Kan Yonemori

1 reference

26 July 2017

7

Kenji Tamura

1 reference

26 July 2017

4

Mayu Yunokawa

1 reference

26 July 2017

8

Masashi Ando

1 reference

26 July 2017

3

Makoto Kodaira

1 reference

26 July 2017

2

Kenji Hashimoto

1 reference

26 July 2017

Hirokazu Shoji

1

1 reference

26 July 2017

publication date

12 April 2012

1 reference

26 July 2017

1 reference

26 July 2017

volume

82

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

228-233

1 reference

Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000.

26 July 2017

cites work

1 reference

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

21 January 2018

1 reference

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

21 January 2018

1 reference

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

21 January 2018

1 reference

Updated Longitudinal Data on Acute Exacerbation of Chronic Hepatitis B in Patients With Breast Cancer Receiving Anthracycline-based Adjuvant Chemotherapy: Therapeutic vs. Pre-emptive Use of Lamivudine

21 January 2018

1 reference

A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

Hepatitis C virus infection does not preclude standard breast cancer-directed therapy

21 January 2018

1 reference

Effects of chronic hepatitis C infection on the treatment of breast cancer patients

21 January 2018

1 reference

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264

21 January 2018

1 reference

Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis

21 January 2018

1 reference

Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000336904

1 reference

26 July 2017

1 reference